Lantheus Prepared To Meet Increased Mo-99 Supply Needs Due To Current Industry Shortage - Meeting Isotope Needs

Main Category: Radiology / Nuclear Medicine
Also Included In: MRI / PET / Ultrasound;  Medical Devices / Diagnostics
Article Date: 09 Sep 2008 - 0:00 PDT

email to a friend   printer friendly   opinions  

Statement Attributable to Don Kiepert, President and CEO, Lantheus Medical Imaging, Inc.

Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, assures regulatory authorities, key customers and partners that they will continue to receive supply of molybdenum-99 (Mo-99), the parent isotope of Technetium-99m (Tc-99m) in their TechneLite generators, during the current global isotope shortage and will continue to fulfill pre-existing standing orders and try to meet additional demands during this critical time.

Lantheus remains committed to serving the needs of patients and the nuclear medicine community, and to mitigating the effect this shortage has on nuclear imaging studies and patient care. On several past occurrences of Tc-99m generator supply issues, Lantheus faced similar challenges and was able to address supply demands. Lantheus is fully prepared for this current situation and has requested additional production of Mo-99 to ensure the company is once again well-positioned in the face of increased customer demand. Lantheus will continue to make every effort in the foreseeable future to provide supply of this medical isotope to the worldwide markets in which the company is permitted to supply until complete resolution of these shortage issues.

Lantheus Medical Imaging, Inc.

• Additional
• References
• Citations